Skip to main content
Chapter
Licensed
Unlicensed Requires Authentication

LYSOSOMAL ENZYMES IN CHRONIC LYMPHOCYTIC LEUKEMIA AND REACTIVE LYMPHOCYTOSIS

  • , , , and
Become an author with De Gruyter Brill
Explore this Subject How to publish with us
[1] Proceedings (selected) of the Third International Congress of Clinical Enzymology Salzburg, Austria, September 6–9, 1981
This chapter is in the book [1] Proceedings (selected) of the Third International Congress of Clinical Enzymology Salzburg, Austria, September 6–9, 1981
© 2019 Walter de Gruyter GmbH, Berlin/Munich/Boston

© 2019 Walter de Gruyter GmbH, Berlin/Munich/Boston

Chapters in this book

  1. Frontmatter I
  2. INTRODUCTION V
  3. LIST OF CONTRIBUTORS VII
  4. CONTENTS XV
  5. SECTION I. ENZYMES IN CANCER
  6. CORRELATIONS AND FACTOR ANALYSIS OF ENZYMES IN SERUM OF PATIENTS WITH HEPATIC METASTASES 3
  7. SPECIFIC ISOZYME PROFILES OF ADENOSINE DEAMINASE IN COLORECTAL ADENOCARCINOMA 11
  8. PLACENTAL TYPE OF AMINOPEPTIDASE M FOUND IN RENAL CELL CARCINOMA: FREQUENCY, AND BIOCHEMICAL AND IMMUNOLOGICAL STUDIES 29
  9. SERUM FUCOSYLTRANSFERASE IN MALIGNANT DISEASES 41
  10. LYSOSOMAL ENZYMES IN CHRONIC LYMPHOCYTIC LEUKEMIA AND REACTIVE LYMPHOCYTOSIS 53
  11. ISOZYMES OF GLYCOLYTIC REGULATOR ENZYMES IN CHRONIC LYMPHOCYTIC LEUKEMIA 61
  12. ENZYMES OF PURINE METABOLISM AS DIAGNOSTIC TOOLS IN ACUTE LYMPHOBLASTIC LEUKEMIA 75
  13. PLASMA LEVELS OF HUMAN GRANULOCYTIC ELASTASE-ci j-PROTEINASE INHIBITOR COMPLEX (E—α1PI) IN PATIENTS WITH SEPTICEMIA AND ACUTE LEUKEMIA 85
  14. SECTION II. ENZYMES IN BLOOD PRESSURE REGULATION
  15. ACTIVATION OF PRORENIN BY PLASMA KALLIKREIN AND PLASMIN 103
  16. BIOCHEMICAL AND FUNCTIONAL ASPECTS OF DIPEPTIDYL CARBOXYPEPTIDASE (ANGIOTENSIN CONVERTING ENZYME) 125
  17. CLINICAL AND EXPERIMENTAL ASPECTS OF THE ANGIOTENSIN CONVERTING ENZYME IN BLOOD PRESSURE REGULATION 131
  18. INCREASE IN ANGIOTENSIN I CONVERTING ENZYME IN ESSENTIAL HYPERTENSION ACCOMPANIED BY ANGINA PECTORIS 147
  19. THE PLASMA RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM DURING CHRONIC DIURETIC THERAPY IN ESSENTIAL HYPERTENSION 155
  20. APPLICATION OF HUMAN RENIN ANTIBODIES 169
  21. EVALUATION OF SERUM ANGIOTENSIN-CONVERTING ENZYME IN DERMATOLOGICAL DISEASES 181
  22. SECTION III. ENZYMES IN BLOOD COAGULATION
  23. REGULATION OF BLOOD COAGULATION BY ACTIVATION AND INHIBITION OF CLOTTING ENZYMES 187
  24. MECHANISMS FOR THE CONVERSION OF BLOOD COAGULATION PROENZYMES TO ENZYMES 201
  25. ACTIVATION AND INHIBITION OF FIBRINOLYTIC ENZYMES 225
  26. COMPLEMENT FACTORS AND LEUKOCYTE ENZYMES RELATED TO COAGULATION 241
  27. SECTION IV. ENZYMES IN DISEASES OF HEART AND MUSCLE
  28. THE ENZYMOLOGY AND ULTRASTRUCTURE OF ACUTE MYOCARDIAL INFARCTION FOLLOWING CORONARY ARTERY OCCLUSION 259
  29. IMMUNOLOGICAL ASSAY OF CREATINE KINASE AND ITS ISOENZYMES 275
  30. VARIANT CREATINE KINASE ISOENZYMES: FREQUENCY AND ANALYTICAL PROBLEMS 295
  31. BIOLUMINESCENCE DETECTION OF CK-MB BY A TWO-SITE IMMUNOASSAY 301
  32. ASSAY OF MALATE DEHYDROGENASE ACTIVITY WITH L-MALATE AS SUBSTRATE AND ITS APPLICATION TO PATIENTS WITH MYOCARDIAL INFARCTION AND LIVER DISEASE 315
  33. LD6, A SIGN OF IMPENDING DEATH FROM HEART FAILURE 333
  34. CHANGES IN PLASMA GOT ISOZYME (APO- AND HOLOENZYME), CPK, DBH AND CYCLIC NUCLEOTIDES IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY 339
  35. ENZYME RELEASE FROM ISOLATED BLOOD CELLS IN DUCHENNE MUSCULAR DYSTROPHY 349
  36. SUBJECT INDEX 355
  37. INDEX OF CONTRIBUTORS 361
  38. Backmatter 363
https://doi.org/10.1515/9783110856880-007

Chapters in this book

  1. Frontmatter I
  2. INTRODUCTION V
  3. LIST OF CONTRIBUTORS VII
  4. CONTENTS XV
  5. SECTION I. ENZYMES IN CANCER
  6. CORRELATIONS AND FACTOR ANALYSIS OF ENZYMES IN SERUM OF PATIENTS WITH HEPATIC METASTASES 3
  7. SPECIFIC ISOZYME PROFILES OF ADENOSINE DEAMINASE IN COLORECTAL ADENOCARCINOMA 11
  8. PLACENTAL TYPE OF AMINOPEPTIDASE M FOUND IN RENAL CELL CARCINOMA: FREQUENCY, AND BIOCHEMICAL AND IMMUNOLOGICAL STUDIES 29
  9. SERUM FUCOSYLTRANSFERASE IN MALIGNANT DISEASES 41
  10. LYSOSOMAL ENZYMES IN CHRONIC LYMPHOCYTIC LEUKEMIA AND REACTIVE LYMPHOCYTOSIS 53
  11. ISOZYMES OF GLYCOLYTIC REGULATOR ENZYMES IN CHRONIC LYMPHOCYTIC LEUKEMIA 61
  12. ENZYMES OF PURINE METABOLISM AS DIAGNOSTIC TOOLS IN ACUTE LYMPHOBLASTIC LEUKEMIA 75
  13. PLASMA LEVELS OF HUMAN GRANULOCYTIC ELASTASE-ci j-PROTEINASE INHIBITOR COMPLEX (E—α1PI) IN PATIENTS WITH SEPTICEMIA AND ACUTE LEUKEMIA 85
  14. SECTION II. ENZYMES IN BLOOD PRESSURE REGULATION
  15. ACTIVATION OF PRORENIN BY PLASMA KALLIKREIN AND PLASMIN 103
  16. BIOCHEMICAL AND FUNCTIONAL ASPECTS OF DIPEPTIDYL CARBOXYPEPTIDASE (ANGIOTENSIN CONVERTING ENZYME) 125
  17. CLINICAL AND EXPERIMENTAL ASPECTS OF THE ANGIOTENSIN CONVERTING ENZYME IN BLOOD PRESSURE REGULATION 131
  18. INCREASE IN ANGIOTENSIN I CONVERTING ENZYME IN ESSENTIAL HYPERTENSION ACCOMPANIED BY ANGINA PECTORIS 147
  19. THE PLASMA RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM DURING CHRONIC DIURETIC THERAPY IN ESSENTIAL HYPERTENSION 155
  20. APPLICATION OF HUMAN RENIN ANTIBODIES 169
  21. EVALUATION OF SERUM ANGIOTENSIN-CONVERTING ENZYME IN DERMATOLOGICAL DISEASES 181
  22. SECTION III. ENZYMES IN BLOOD COAGULATION
  23. REGULATION OF BLOOD COAGULATION BY ACTIVATION AND INHIBITION OF CLOTTING ENZYMES 187
  24. MECHANISMS FOR THE CONVERSION OF BLOOD COAGULATION PROENZYMES TO ENZYMES 201
  25. ACTIVATION AND INHIBITION OF FIBRINOLYTIC ENZYMES 225
  26. COMPLEMENT FACTORS AND LEUKOCYTE ENZYMES RELATED TO COAGULATION 241
  27. SECTION IV. ENZYMES IN DISEASES OF HEART AND MUSCLE
  28. THE ENZYMOLOGY AND ULTRASTRUCTURE OF ACUTE MYOCARDIAL INFARCTION FOLLOWING CORONARY ARTERY OCCLUSION 259
  29. IMMUNOLOGICAL ASSAY OF CREATINE KINASE AND ITS ISOENZYMES 275
  30. VARIANT CREATINE KINASE ISOENZYMES: FREQUENCY AND ANALYTICAL PROBLEMS 295
  31. BIOLUMINESCENCE DETECTION OF CK-MB BY A TWO-SITE IMMUNOASSAY 301
  32. ASSAY OF MALATE DEHYDROGENASE ACTIVITY WITH L-MALATE AS SUBSTRATE AND ITS APPLICATION TO PATIENTS WITH MYOCARDIAL INFARCTION AND LIVER DISEASE 315
  33. LD6, A SIGN OF IMPENDING DEATH FROM HEART FAILURE 333
  34. CHANGES IN PLASMA GOT ISOZYME (APO- AND HOLOENZYME), CPK, DBH AND CYCLIC NUCLEOTIDES IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY 339
  35. ENZYME RELEASE FROM ISOLATED BLOOD CELLS IN DUCHENNE MUSCULAR DYSTROPHY 349
  36. SUBJECT INDEX 355
  37. INDEX OF CONTRIBUTORS 361
  38. Backmatter 363
Downloaded on 7.5.2026 from https://www.degruyterbrill.com/document/doi/10.1515/9783110856880-007/html?lang=en
Scroll to top button